MNKD

#2582
Mannkind Corporation
2.7050 USD
+2.46%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
2.6900
2.7100
Year Range
2.2300
6.5100
Daily Change
+2.46%
Monthly Change
-2.35%
6 month change
-48.96%
Year Change
-48.96%
Previous Close
2.6400
Open
2.7050
Bid
Ask
Low
2.6900
High
2.7100
Volume
371
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 833.4117 M
  • Employee 592
  • Founded N/A
  • CEO Michael Castagna
  • Website www.mannkindcorp.com
  • Headquarter Delaware, United States
  • FIGI BBG000PPL3G9
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
283.5
Price to sales ratio
5.25

MannKind Corporation

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991. MannKind Corporation was named after its founder, Alfred E. Mann.

News